Back to All Events

What We Know, What We Presume: The Limits of Evidence in Modern Pain Management

What We Know, What We Presume: The Limits of Evidence in Modern Pain Management

Date and Time:
Tuesday, August 5th, Noon EST       

Location – Virtual Meeting
https://us02web.zoom.us/j/83722922366?pwd=QjZ3V0xNWHZ0OVZ0b3BpbWd3STRqUT09

Event Description:

As access to cannabinoids for chronic pain continues to expand, clinicians are increasingly confronted with questions about its safety, efficacy, and role in long-term management. The August journal club will examine the American College of Physicians' 2025 clinical guidance on cannabis and cannabinoids for chronic noncancer pain. We'll unpack what the evidence says—and doesn’t say—about benefits, short- and long-term harms, and best practices for clinician–patient discussions.

Featured Article:

Kansagara, D. et al. Cannabis or Cannabinoids for the Management of Chronic Noncancer Pain: Best Practice Advice From the American College of Physicians. Ann. Intern. Med. 178, 714–724 (2025). DOI: 10.7326/annals-24-03319 

Speakers:

  • Phil Molloy, MD – Clinical education expert

  • Teresa Simon, MPH – Public health epidemiologist

  • Len Kamen, MD – Clinical pain specialist

  • Jahan Marcu, PhD – Cannabis researcher

Questions? Email Prctrials.info@gmail.com

PRC+ has education modules available for health care professionals: https://www.prc-trials-plus.com/education

 

 

Previous
Previous
June 3

Neurodegeneration Meets Neuroregulation: Cannabinoids, ALS, and the Endocannabinoid System

Next
Next
August 17

The Educational Landscape of Cannabis at the American Chemical Society Meeting (with CANN)